Two researchers from the Bellvitge Biomedical Research Institute (IDIBELL), have been awarded in this edition of the City of Barcelona Awards, in the Life Sciences category. Dr. Antonella Consiglio, principal investigator of the group of stem cells and neurodegenerative diseases of IDIBELL, ICREA academy researcher, and professor at the Faculty of Medicine and Health Sciences […]
The work shows that patients with low levels of this protein have a better prognosis.
Inhibition of p38 reduces the growth of lung tumors Read More »
In World Cancer Day, NanoMed organizes the seventh edition of the HealthTech World Cancer Day. An event in which the latest innovations in nanomedicine cancer filed, will be announced. Experts will talk about issues ranging from early diagnosis, controlled drug release or radiotherapy with nanoparticles. The Bioengineering Institute of Catalonia (IBEC) and the Bellvitge Biomedical
On World Cancer Day we will celebrate HealthTech World Day Read More »
The European Medicines Agency (EMA) has approved dimethyl fumarate (DMF) as an orphan drug for the treatment of adrenoleukodystrophy, a rare fatal neurometabolic disorder. Dimethyl fumarate is an activator of the NFR2 pathway, which enhances cellular defense and protection against oxidative damage. Dimethyl fumarate can reduce the inflammatory response and promote the protection of central
A group of Catalan researchers, led by the director of the digestive endoscopy Unit of the Digestive Pathology Service of the Hospital de Sant Pau de Barcelona – IIB Sant Pau, Carles Guarner Argente, have published an article in Gastroenterology in which, it is shown that the antibiotic prophylaxis is not necessary for ultrasound-guided endoscopic
Catalan researchers propose a new protocol for an endoscopic puncture in the pancreas Read More »
IDIBELL researchers have used gene-editing technology in C. elegans to reproduce human mutations that cause retinitis pigmentaria. With this method, they have studied factors that affect disease development and possible drug treatments. Often, patients from the same family and carriers of the same genetic mutation, develop a disease differently. This disparity may be due
Avatar worms help to identify factors that modify genetic diseases Read More »
The 3rd SLHAM of women scientists will take place on Saturday, February 8 at 7 pm at the Auditori Barradas, in L’Hospitalet. Nine women researchers and professionals from the Bellvitge Biomedical Research Institute (IDIBELL) will participate. Each of them will explain their work concerning research and innovation through a five-minute informative talk. The 2020 edition
3rd SLHAM of women scientists of IDIBELL arrives Read More »
Three IDIBELL researchers have received funding from the European Union to develop research projects within the framework of the Work Program on Health of Social Challenges, in the context of the Horizon 2020 research and innovation program, in its 2019 call. H2020 is an extremely competitive research program, with a strong focus on excellence, innovation
Three IDIBELL researchers receive funding from the EU H2020 program Read More »
On December 20th, the Joventut Theater hosted the extraordinary Christmas concert of L’Hospitalet and IDIBELL, starring this year by the Vallès Symphony Orchestra. About 500 spectators enjoyed a show that, as it is traditional, had a solidarity character, since all the raised money will go to biomedical research, specifically, to cancer research projects led by
IDIBELL has held its annual transparency session, by the director of the institution, Dr. Gabriel Capellá. Before an audience of 170 people, gathered in the Pau Viladiu Conference Hall of the Duran i Reynals Hospital, Capellá has pointed the various items of a detailed and exhaustive report that, in summary, has laid special emphasis on
Gabriel Capellá takes stock of the year in the IDIBELL transparency session Read More »
